<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Odio CD</submitter><funding>U.S. Department of Health &amp;amp; Human Services | NIH | National Institute of Allergy and Infectious Diseases (NIAID)</funding><funding>NIAID NIH HHS</funding><pagination>191</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11697199</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>16(1)</volume><pubmed_abstract>The standard dengue virus (DENV) neutralization assay inconsistently predicts dengue protection. We compare how IgG ELISA, envelope domain III (EDIII), or non-structural protein 1 (NS1) binding antibodies, and titers from plaque reduction neutralization tests (PRNTs) using standard and mature viruses are associated with dengue. The ELISA measures IgG antibodies that bind to inactivated DENV1-4. The EDIII and NS1 assays measure binding antibodies, and the PRNTs measure neutralizing antibodies to each specific DENV serotype. Healthy children (n = 1206) in Cebu, Philippines were followed for 5 years. ELISA IgG≥3 was associated with reduced dengue probability relative to naïve children (3% vs. 10%, p = 0.007). Serotype-specific antibodies binding EDIII or NS1 had no association with dengue ris</pubmed_abstract><journal>Nature communications</journal><pubmed_title>Dengue virus IgG and neutralizing antibody titers measured with standard and mature viruses are protective.</pubmed_title><pmcid>PMC11697199</pmcid><funding_grant_id>P01AI106695</funding_grant_id><funding_grant_id>P01 AI106695</funding_grant_id><pubmed_authors>Katzelnick LC</pubmed_authors><pubmed_authors>Adams C</pubmed_authors><pubmed_authors>Aogo RA</pubmed_authors><pubmed_authors>Firdous S</pubmed_authors><pubmed_authors>Ylade M</pubmed_authors><pubmed_authors>de Silva AM</pubmed_authors><pubmed_authors>Odio CD</pubmed_authors><pubmed_authors>Agrupis KA</pubmed_authors><pubmed_authors>Voirin CJ</pubmed_authors><pubmed_authors>Dahora Hein L</pubmed_authors><pubmed_authors>Abad Fernandez M</pubmed_authors><pubmed_authors>Mpingabo PI</pubmed_authors><pubmed_authors>White LJ</pubmed_authors><pubmed_authors>Crisostomo MV</pubmed_authors><pubmed_authors>Coello Escoto A</pubmed_authors><pubmed_authors>Raimundi Rodriguez G</pubmed_authors><pubmed_authors>Deen J</pubmed_authors><pubmed_authors>Daag JV</pubmed_authors></additional><is_claimable>false</is_claimable><name>Dengue virus IgG and neutralizing antibody titers measured with standard and mature viruses are protective.</name><description>The standard dengue virus (DENV) neutralization assay inconsistently predicts dengue protection. We compare how IgG ELISA, envelope domain III (EDIII), or non-structural protein 1 (NS1) binding antibodies, and titers from plaque reduction neutralization tests (PRNTs) using standard and mature viruses are associated with dengue. The ELISA measures IgG antibodies that bind to inactivated DENV1-4. The EDIII and NS1 assays measure binding antibodies, and the PRNTs measure neutralizing antibodies to each specific DENV serotype. Healthy children (n = 1206) in Cebu, Philippines were followed for 5 years. ELISA IgG≥3 was associated with reduced dengue probability relative to naïve children (3% vs. 10%, p = 0.007). Serotype-specific antibodies binding EDIII or NS1 had no association with dengue ris</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Jan</publication><modification>2026-06-02T02:04:52.551Z</modification><creation>2025-04-05T22:50:51.93Z</creation></dates><accession>S-EPMC11697199</accession><cross_references><pubmed>39747846</pubmed><doi>10.1038/s41467-024-53916-9</doi></cross_references></HashMap>